A Phase 1 Study of HDM2017 in Advanced Solid Tumors

NCT07274085 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: HDM2017

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.